Fibrodysplasia Ossificans Progressiva is a rare debilitating disorder of the musculoskeletal system affecting one in two million individuals. It is characterized by progressive extraskeletal ossification of soft tissues resulting in the original skeleton being encased in unyielding new bone leading to disability and ultimately death from cardiorespiratory failure. The present case brings to light the delays and potential pitfalls in diagnosis as a result of the rarity of the condition.
INTRODUCTION
Fibrodysplasia Ossificans Progressiva (Munchmeyer's disease, stoneman's disease, Myositis Ossificans Progressiva) first described by Guy Patin in 1692, 1,2 is a rare progressively disabling disease characterized by congenital malformations of the great toes and extraskeletal bone formation that gradually encases the original skeleton resulting in restriction of movement and eventual immobility and mortality from cardiorespiratory complications around the fourth decade of life. 1, 3 It is extremely rare with an incidence of one in two million individuals occurring without bias to gender, race or ethnicity. 4 It is an autosomal dominant disorder with most patients having a spontaneous new mutation of a bone morphogenic protein type 1 receptor (ACVR1) which results in activation of osteogenesis in ectopic sites without ligand binding. 5, 6 Familial cases have also been reported. 7 Individuals are born usually following an uneventful gestation but the great toe abnormalities are almost invariably present at birth. 2, 4 These include hallux valgus, shortened great toes and sharpening of the first metatarsal bone. 8 In the first decade of life, intermittent episodes of painful soft tissue swellings occur which progress to become the hard, bony lesions that characterize the disease. Biopsy reveals endochondral bone formation in ectopic sites but predictably leads to worsening of the condition with explosive new bone formation and calcification as has been seen in individuals who have inadvertently had a biopsy.
Early diagnosis slows progression of the disease and crucially helps to avoid biopsies or procedures that result in florid exacerbations.
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CASE REPORT
A nine-year-old boy presented with a five year history of multiple neck and back swellings. He was the product of a normal term pregnancy with non-consanguineous parents and no other member of his extended family had similar swellings.
Clinical records reveal that at the age of four, he was diagnosed with probable spinal tuberculosis but didn't undergo treatment because there wasn't additional supporting clinical or laboratory evidence.
At the age of six, he was managed as a case of multiple exostoses and was treated non-operatively but was subsequently lost to follow-up.
He re-presented at the age of nine with neck swelling, stiffness, pain and numerous bony swellings over the occiput, the posterior neck, parascapular and thoracolumbar paraspinal regions. (Figures 1A and 1B) Further examination revealed bilateral big toe malformations (hallux valgus) that had been present since birth but wasn't of concern to the patient nor his parents. The family was advised against a biopsy or excision of the lesions. Analgesics and oral prednisolone were given for the period of the flare-up with resolution of the acute symptoms after three weeks and he is presently able to attend school regularly.
The patient and his parents were counseled regarding the cause, course and prognosis of the disease and the availability of support groups like the International Fibrodysplasia Ossificans Progressiva Association (IFOPA).
DISCUSSION
Fibrodysplasia ossificans progressiva (FOP) is a rare disease with peculiar phenotypic features of extraskeletal new bone formation and great toe abnormalities. It is unsurprising the diagnosis wasn't made in this patient until the fifth year after initial presentation.
A survey from five continents by Kitterman et al showed erroneous diagnoses in about 90% with 67% of patients being subjected to potentially harmful invasive diagnostic procedures. 4, [7] [8] [9] [10] Awareness across a wide spectrum of practitioners is key to early diagnosis and prevention of injurious diagnostic or therapeutic interventions. Although it is a rare disease, the clinical features are unique and unambiguous and genetic testing has recently become available. 2, 5 A biopsy is contraindicated due to risk of catastrophic explosive new bone formation. 2, 10, 11 Disease flare-ups may be precipitated by trauma including intramuscular injections, lesion biopsies and nerve blocks especially around the temporomandibular joint. 4, [10] [11] [12] [13] There is presently no cure for the disease. A multitude of therapeutic agents have been tried without success but some selected agents like palovarotene currently undergoing clinical trials have shown some promise. [14] [15] [16] Currently analgesia with non-steroidal antiinflammatory drugs and a short course of steroids started at the onset of a flare-up are the mainstay of treatment during "flare-ups."
